{"id":"W4236870775","doi":"10.2165/00128415-200309640-00002","title":"Novo Nordisk Canada Inc. has informed healthcare professionals that the concomitant use of repaglinide and gemfibrozil is now contraindicated,","year":2003,"lang":"en","type":"article","venue":"Reactions Weekly","topic":"Cardiovascular Syncope and Autonomic Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"","keywords":"Gemfibrozil; Repaglinide; Concomitant; Health professionals; Medicine; Health care; Pharmacology; Intensive care medicine; Political science; Internal medicine; Law; Metformin","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002720869,0.0002968362,0.0004234631,0.000586627,0.001657107,0.001370278,0.0006290229,0.005575717,0.02257066],"category_scores_gemma":[0.01214874,0.000321619,0.0003853273,0.000415834,0.0006886409,0.0006365891,0.0005195492,0.005204971,0.004498021],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002693071,"about_ca_system_score_gemma":0.01068356,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.108453,"about_ca_topic_score_gemma":0.2252786,"domain_scores_codex":[0.9986055,0.0002997804,0.0001775313,0.00009837339,0.0006512973,0.0001674956],"domain_scores_gemma":[0.9903315,0.004427243,0.0006139395,0.0003566755,0.003028326,0.001242429],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0006439319,0.0001801753,0.006991765,0.0004376776,0.00002798294,0.001995274,0.0004572614,0.0002145884,0.004957693,0.009147497,0.7817147,0.1932314],"study_design_scores_gemma":[0.00007701881,0.0000930198,0.005904883,0.000202175,0.00003178424,0.0007512169,0.0002013761,0.0001680583,0.001310729,0.0008788413,0.9903486,0.00003230805],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"editorial","genre_scores_codex":[0.03007678,0.02865448,0.004744718,0.5603303,0.01840276,0.0003369135,0.003908342,0.0007821553,0.3527636],"genre_scores_gemma":[0.2032595,0.03428308,0.02119587,0.1998866,0.006883164,0.0001879068,0.003739886,0.0004867644,0.5300772],"genre_candidate":"editorial","genre_consensus":null,"teacher_disagreement_score":0.891547,"threshold_uncertainty_score":0.2156434,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03866814944724065,"score_gpt":0.2778605089024198,"score_spread":0.2391923594551791,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}